Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group.
Bonfanti P, Pusterla L, Parazzini F, Libanore M, Cagni AE, Franzetti M, Faggion I, Landonio S, Quirino T. Bonfanti P, et al. Among authors: pusterla l. Biomed Pharmacother. 2000 Feb;54(1):45-9. doi: 10.1016/s0753-3322(00)88640-0. Biomed Pharmacother. 2000. PMID: 10721462 Free article. Clinical Trial.
Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group.
Bonfanti P, Valsecchi L, Parazzini F, Carradori S, Pusterla L, Fortuna P, Timillero L, Alessi F, Ghiselli G, Gabbuti A, Di Cintio E, Martinelli C, Faggion I, Landonio S, Quirino T. Bonfanti P, et al. Among authors: pusterla l. J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):236-45. doi: 10.1097/00126334-200003010-00004. J Acquir Immune Defic Syndr. 2000. PMID: 10839659
Osteonecrosis in protease inhibitor-treated patients.
Bonfanti P, Grabbuti A, Carradori S, Pusterla L, Parrazini F, Landonio S, Quirino T; Italian Coordination for the Study of Allergies and HIV Infection. Bonfanti P, et al. Among authors: pusterla l. Orthopedics. 2001 Mar;24(3):271-2. doi: 10.3928/0147-7447-20010301-19. Orthopedics. 2001. PMID: 11300292
Risk factors for lipodystrophy in the CISAI cohort.
Bonfanti P, Gulisano C, Ricci E, Timillero L, Valsecchi L, Carradori S, Pusterla L, Fortuna P, Miccolis S, Magnani C, Gabbuti A, Parazzini F, Martinelli C, Faggion I, Landonio S, Quirino T, Vigevani G; Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group. Bonfanti P, et al. Among authors: pusterla l. Biomed Pharmacother. 2003 Nov;57(9):422-7. doi: 10.1016/j.biopha.2003.06.002. Biomed Pharmacother. 2003. PMID: 14652168 Clinical Trial.
HIV and metabolic syndrome: a comparison with the general population.
Bonfanti P, Giannattasio C, Ricci E, Facchetti R, Rosella E, Franzetti M, Cordier L, Pusterla L, Bombelli M, Sega R, Quirino T, Mancia G. Bonfanti P, et al. Among authors: pusterla l. J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):426-31. doi: 10.1097/QAI.0b013e318074ef83. J Acquir Immune Defic Syndr. 2007. PMID: 17514013
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project.
Madeddu G, Bonfanti P, De Socio GV, Carradori S, Grosso C, Marconi P, Penco G, Rosella E, Miccolis S, Melzi S, Mura MS, Landonio S, Ricci E, Quirino T; CISAI Group. Madeddu G, et al. Biomed Pharmacother. 2008 Jan;62(1):6-11. doi: 10.1016/j.biopha.2007.04.008. Epub 2007 May 29. Biomed Pharmacother. 2008. PMID: 17574807
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
D:A:D Study Group; Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD. D:A:D Study Group, et al. Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Lancet. 2008. PMID: 18387667 Free PMC article.
24 results